Paromomycin was granted orphan drug status in 2005 and was approved by the Drug Controller General of India in September 2006 for treatment visceral leishmaniasis.
Paromomycin was granted orphan drug status in 2005. Paromomycin was approved by the Drug Controller General of India in September 2006 for treatment visceral leishmaniasis.